The US pharmaceutical industry export market share stood at 8.84% in 2023. From 2024 to 2028, the forecast shows the market share remaining constant at 8.84% annually. This indicates no year-on-year variation during this period. Given the steady percentage, the CAGR over the next five years is 0%.
Future trends to watch include:
- Potential regulatory changes impacting international trade agreements
- Advancements in biotechnology and personalized medicine which might shift market dynamics
- Economic factors such as exchange rates and trade tariffs
- Competition from emerging pharmaceutical markets